#China #Suzhou #Natus Medical #Nicolet EDX

Natus Medical Unveils Locally Manufactured Nicolet EDX System in China

Natus Medical Incorporated, the largest dedicated neurodiagnostic company globally, has recently announced the launch of the Nicolet EDX EMG system in China. This development marks a pivotal moment for the company, as it is the first product developed and manufactured within the People's Republic of China.

Natus has established a significant presence in China, recognized as a vital market for its operations. Walter Wang, the General Manager for Natus in China, emphasized the company's longstanding collaboration with top hospitals across the region. He stated, "With the introduction of our locally manufactured capabilities, we are not only expanding our reach but also enhancing access to cutting-edge neurodiagnostic technologies for healthcare professionals and patients across the country."

The Nicolet EDX system stands out as the most advanced EMG system offered by Natus, renowned for delivering exceptional performance and features that healthcare institutions rely on for accurate diagnostic outcomes. The system was approved by the National Medical Products Administration on June 18, making it the first locally manufactured Natus product available in China. This approval marks a significant achievement, reinforcing Natus's commitment to the Chinese market, where there is a growing emphasis on sourcing medical technologies domestically.

Wang added, "This launch is not just about local production; it integrates our global expertise, standards, and technological advancements with the local dynamics, talent, and insights provided by our team in China. This effort underscores our promise to support clinicians and patients throughout the region."

Engineered for routine EMG assessments and intricate neuromuscular diagnoses, the Nicolet EDX system serves as a comprehensive and adaptable platform, allowing clinicians to conduct tests with improved confidence and efficiency.

Natus' new manufacturing facility is located in Suzhou, a city recognized as a prominent industrial center in Eastern China. To commemorate this meaningful step and product launch, a ceremony will be held in Suzhou on October 27, illustrating the fruitful collaboration behind establishing this site and integrating its offerings into the local healthcare ecosystem.

As a trusted resource for healthcare providers worldwide, Natus remains committed to offering solutions for screening, diagnosing, and treating neurological disorders effectively. The company’s innovative solutions, combined with robust service and educational support, empower healthcare professionals to elevate their standards of care, ultimately enhancing patient outcomes and quality of life. To learn more about Natus and its offerings, interested parties can visit their website at natus.com/neuro.